樂普醫療(300003.SZ):心泰科技擬針對公司及心泰科技核心員工實施持股計劃
格隆匯5月14日丨樂普醫療(300003.SZ)公佈,公司控股子公司樂普心泰醫療科技(上海)股份有限公司(以下簡稱:心泰科技)擬發行境外上市外資股(H股)股票並申請在香港聯合交易所有限公司主板上市。為實現公司中長期發展戰略,充分調動核心員工工作積極性,實現利益共享和風險共擔,心泰科技搭建持股平台擬針對公司及心泰科技核心員工實施持股計劃。
由公司全資子公司北京樂普成長投資管理有限公司作為執行事務合夥人的寧波嘉度企業管理合夥企業(有限合夥)(以下簡稱:寧波嘉度)和寧波嘉呈企業管理合夥企業(有限合夥)(以下簡稱:寧波嘉呈)合計持有心泰科技5%的股份將作為本次持股計劃的股份來源。
心泰科技作為公司結構性心臟病醫療器械平台,通過分拆到香港聯合交易所有限公司主板上市,可拓寬融資渠道,提升其研發能力和行業競爭力。此次分拆實施後,公司仍是心泰科技控股股東,隨着心泰科技盈利能力的增強,將進一步提升公司的盈利水平。
為保障公司中長期發展戰略的實施,充分調動核心員工工作積極性,公司實施員工持股計劃將有利於公司綜合實力的提升,實現可持續發展的目標。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.